Category: Industry insights and trends

How a major pharmaceutical collaboration highlighted the critical need for interrogable data pipelines in the era of machine learning

Why scientific judgement still matters in AI-driven drug discovery

Seoul in late April moves at a pace that feels appropriate for a city hosting one of Asia’s most significant life sciences gatherings. BioKorea 2026 drew dealmakers, investors, and business development executives from across the globe

For decades, the story of pharmaceutical innovation followed a familiar path.

The Protein Data Bank (PDB) now holds over 250,000 structures.

Why stronger collaboration is still one of the biggest untapped opportunities in drug discovery